[go: up one dir, main page]

AU3888100A - Therapeutic and diagnostic applications of p400: a newly discovered beta-amyloidbinding protein present in human biological fluids - Google Patents

Therapeutic and diagnostic applications of p400: a newly discovered beta-amyloidbinding protein present in human biological fluids

Info

Publication number
AU3888100A
AU3888100A AU38881/00A AU3888100A AU3888100A AU 3888100 A AU3888100 A AU 3888100A AU 38881/00 A AU38881/00 A AU 38881/00A AU 3888100 A AU3888100 A AU 3888100A AU 3888100 A AU3888100 A AU 3888100A
Authority
AU
Australia
Prior art keywords
amyloidbinding
therapeutic
biological fluids
diagnostic applications
protein present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38881/00A
Inventor
Gerardo Castillo
Alan D. Snow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProteoTech Inc
Original Assignee
ProteoTech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProteoTech Inc filed Critical ProteoTech Inc
Publication of AU3888100A publication Critical patent/AU3888100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU38881/00A 1999-03-15 2000-03-15 Therapeutic and diagnostic applications of p400: a newly discovered beta-amyloidbinding protein present in human biological fluids Abandoned AU3888100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12446299P 1999-03-15 1999-03-15
US60124462 1999-03-15
PCT/US2000/006878 WO2000055187A1 (en) 1999-03-15 2000-03-15 Therapeutic and diagnostic applications of p400: a newly discovered beta-amyloid binding protein present in human biological fluids

Publications (1)

Publication Number Publication Date
AU3888100A true AU3888100A (en) 2000-10-04

Family

ID=22415039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38881/00A Abandoned AU3888100A (en) 1999-03-15 2000-03-15 Therapeutic and diagnostic applications of p400: a newly discovered beta-amyloidbinding protein present in human biological fluids

Country Status (2)

Country Link
AU (1) AU3888100A (en)
WO (1) WO2000055187A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070208087A1 (en) 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
EP2527315B1 (en) 2002-05-31 2014-03-19 Proteotech Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
ES2536436T3 (en) 2008-12-05 2015-05-25 C2N Diagnostics Methods to measure biomolecule concentrations
US20140315327A1 (en) * 2011-12-02 2014-10-23 C2N Diagnostics Methods for Measuring Concentrations of Biomolecules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US5958883A (en) * 1992-09-23 1999-09-28 Board Of Regents Of The University Of Washington Office Of Technology Animal models of human amyloidoses

Also Published As

Publication number Publication date
WO2000055187A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
AU2003251127A1 (en) Improvements in and relating to control of liquid flow into or out of a human or animal body
AU2002347575A1 (en) Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
AU2001289037A1 (en) Electrical stimulation of tissue for therapeutic and diagnostic purposes
AU2200797A (en) Extracorporeal whole body hyperthermia using alpha-stat regulation of blood ph and pc02
AU2002308348A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
AU2002246808A1 (en) Human nucleic acids and polypeptides and methods of use thereof
AU4104200A (en) Cdna molecules of the members of gene family encoding human fatty acid desaturases and their use in diagnosis and therapy
HUP0201997A2 (en) Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
AU3888100A (en) Therapeutic and diagnostic applications of p400: a newly discovered beta-amyloidbinding protein present in human biological fluids
AU3177500A (en) Proteins for diagnosis and treatment of breast cancer
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
AU2003244498A1 (en) Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
AU2003258550A1 (en) Splicing-variant of the human p53 protein and use thereof in the production of pharmaceutical preparations for treating tumoural diseases
AU2003240253A1 (en) Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
AU2001245693A1 (en) Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
AU4293600A (en) Recombinant protein uk114 and its use in therapy and diagnostics
AU2002248135A1 (en) Preparation of replicating kupffer cells and their use in diagnosis and therapy
AU5876399A (en) Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
GB9917878D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9906217D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
AU2001289861A1 (en) Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase